Brandon M. Johnson

2.1k total citations · 1 hit paper
15 papers, 924 citations indexed

About

Brandon M. Johnson is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Brandon M. Johnson has authored 15 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 6 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Brandon M. Johnson's work include interferon and immune responses (7 papers), Immune Response and Inflammation (3 papers) and Immune cells in cancer (3 papers). Brandon M. Johnson is often cited by papers focused on interferon and immune responses (7 papers), Immune Response and Inflammation (3 papers) and Immune cells in cancer (3 papers). Brandon M. Johnson collaborates with scholars based in United States, Sweden and Netherlands. Brandon M. Johnson's co-authors include Karen P. McKinnon, Eric M. Bachelder, Kristy M. Ainslie, Robert D. Junkins, Jenny P.‐Y. Ting, Jenny P.‐Y. Ting, Clément N. David, Ning Cheng, Meng Deng and W. June Brickey and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and Immunity.

In The Last Decade

Brandon M. Johnson

15 papers receiving 916 citations

Hit Papers

STING-induced regulatory B cells compromise NK function i... 2022 2026 2023 2024 2022 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brandon M. Johnson United States 10 640 332 155 142 128 15 924
Aqu Alu China 13 364 0.6× 397 1.2× 254 1.6× 193 1.4× 125 1.0× 22 1.0k
Xuejiao Han China 12 504 0.8× 540 1.6× 165 1.1× 289 2.0× 145 1.1× 21 1.1k
Manisha Singh United States 18 519 0.8× 282 0.8× 84 0.5× 399 2.8× 120 0.9× 47 1.2k
Fangfang Chen China 14 303 0.5× 329 1.0× 51 0.3× 82 0.6× 155 1.2× 27 880
Robert D. Junkins Canada 16 647 1.0× 433 1.3× 143 0.9× 106 0.7× 103 0.8× 21 939
Gregory R. Robbins United States 11 356 0.6× 398 1.2× 40 0.3× 57 0.4× 180 1.4× 12 960
Zichao Huang China 16 405 0.6× 409 1.2× 32 0.2× 157 1.1× 307 2.4× 45 968
Rodolphe Carpentier France 20 207 0.3× 405 1.2× 52 0.3× 80 0.6× 85 0.7× 28 1.4k

Countries citing papers authored by Brandon M. Johnson

Since Specialization
Citations

This map shows the geographic impact of Brandon M. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandon M. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandon M. Johnson more than expected).

Fields of papers citing papers by Brandon M. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandon M. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandon M. Johnson. The network helps show where Brandon M. Johnson may publish in the future.

Co-authorship network of co-authors of Brandon M. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Brandon M. Johnson. A scholar is included among the top collaborators of Brandon M. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandon M. Johnson. Brandon M. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Johnson, Brandon M., et al.. (2024). Nonclinical evaluations of deucravacitinib and Janus kinase inhibitors in homeostatic and inflammatory pathways. Frontiers in Immunology. 15. 1437512–1437512. 1 indexed citations
2.
Li, Sirui, Bhalchandra Mirlekar, Brandon M. Johnson, et al.. (2022). STING-induced regulatory B cells compromise NK function in cancer immunity. Nature. 610(7931). 373–380. 213 indexed citations breakdown →
3.
Johnson, Brandon M., Matthew D. Gallovic, Madhan Thamilarasan, et al.. (2021). STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN–Dependent and –Independent Immune-Regulatory Pathways. The Journal of Immunology. 206(9). 2015–2028. 22 indexed citations
4.
Deng, Meng, Haitao Guo, Jason W. Tam, et al.. (2019). Platelet-activating factor (PAF) mediates NLRP3-NEK7 inflammasome induction independently of PAFR. The Journal of Experimental Medicine. 216(12). 2838–2853. 43 indexed citations
5.
Johnson, Brandon M., et al.. (2019). Adult moped-related injuries treated in U.S. emergency departments. Traffic Injury Prevention. 20(8). 813–819. 3 indexed citations
6.
Collier, Michael A., Robert D. Junkins, Matthew D. Gallovic, et al.. (2018). Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists. Molecular Pharmaceutics. 15(11). 4933–4946. 68 indexed citations
7.
Cheng, Ning, Robert D. Junkins, Clément N. David, et al.. (2018). A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer. JCI Insight. 3(22). 211 indexed citations
8.
Oyama, Yoshitaka, Meng Deng, Haitao Guo, et al.. (2018). The Innate Immune Sensor NLRC3 Acts as a Rheostat that Fine-Tunes T Cell Responses in Infection and Autoimmunity. Immunity. 49(6). 1049–1061.e6. 60 indexed citations
9.
Cheng, Ning, Robert D. Junkins, Clément N. David, et al.. (2018). Abstract LB-126: Nanoparticle-incorporated STING activator as an immunotherapeutic for PD-L1 resistant triple-negative breast cancer. Cancer Research. 78(13_Supplement). LB–126. 2 indexed citations
10.
Johnson, Brandon M., et al.. (2017). Pediatric moped-related injuries in the United States from 2002 to 2014: Age-related comparisons of mechanisms and outcomes. The Journal of Trauma: Injury, Infection, and Critical Care. 83(5S). S201–S209. 2 indexed citations
11.
Junkins, Robert D., Matthew D. Gallovic, Brandon M. Johnson, et al.. (2017). A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination. Journal of Controlled Release. 270. 1–13. 125 indexed citations
12.
Junkins, Robert D., Brandon M. Johnson, Matthew D. Gallovic, et al.. (2017). A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination. The Journal of Immunology. 198(Supplement_1). 199.14–199.14. 4 indexed citations
13.
Roberts, Reid A., Timothy K. Eitas, James D. Byrne, et al.. (2015). Towards programming immune tolerance through geometric manipulation of phosphatidylserine. Biomaterials. 72. 1–10. 47 indexed citations
14.
Johnson, Brandon M., Joseph A. Fraietta, Donald T. Gracias, et al.. (2014). Acute exposure to ZnO nanoparticles induces autophagic immune cell death. Nanotoxicology. 9(6). 737–748. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026